> Kennedy Institute of Ethics
> Personalized Medicine Coalition
Morning panelists include:
> Finley Austin, Ph.D., Head, US External Research & Innovation Environment, Hoffmann-La Roche, Inc.
> Greg Downing, D.O., Ph.D., Program Director, Personalized Health Care, Immediate Office of the Secretary, Department of Health and Human Services
> Carolina Hinestrosa, M.A., M.P.H., Executive Vice President of Programs and Planning, National Breast Cancer Coalition
> Howard. P. Levy, M.D., Ph.D., Assistant Professor, Division of General Internal Medicine and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University
> Kavita Patel, M.D., M.S.H.S., Deputy Staff Director, Health Subcommittee of Senator Edward M. Kennedy
> Joan A. Scott, M.S., C.G.C., Deputy Director, Genetics and Public Policy Center, Johns Hopkins University
> Charles Rotimi, Ph.D., Director, NIH Intramural Center for Genomics and Health Disparities; Senior Investigator, Inherited Disease Research Branch, NHGRI
> Grail Sipes, J.D., Partner, Covington & Burling
Afternoon panelists include:
> Kevin T. Conroy, President and CEO, Third Wave Technologies, Inc.
> Steven I. Gutman, Ph.D., Director, Office of In Vitro Diagnostic Device Evaluation & Safety, CDRH, FDA
> Shiew-Mei Huang, Ph.D., Deputy Director for Science, Office of Clinical Pharmacology, CDER, FDA
> Steve McPhail, President and Chief Executive Officer, Expression Analysis, Inc.
> Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag LLP
> Allen D. Roses, M.D., Jefferson-Pilot Professor of Neurobiology and Genetics, Professor of Medicine, and Director, Deane Drug Discovery Institute, Duke University Medical Center; Senior Scholar, Fuqua School of Business; Member, Duke Institute of Genome Sciences and Policy
Jeffery N. Gibbs, Principal at Hyman, Phelps & McNamara, P.C. and Gail
|SOURCE Food and Drug Law Institute|
Copyright©2008 PR Newswire.
All rights reserved